These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16908336)

  • 1. Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts.
    Coyne KS; Tubaro A; Brubaker L; Bavendam T
    Urology; 2006 Aug; 68(2 Suppl):9-16. PubMed ID: 16908336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
    Brubaker L; Chapple C; Coyne KS; Kopp Z
    Urology; 2006 Aug; 68(2 Suppl):3-8. PubMed ID: 16908335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
    Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
    Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes in overactive bladder: the influence of perception of condition and expectation for treatment benefit.
    Marschall-Kehrel D; Roberts RG; Brubaker L
    Urology; 2006 Aug; 68(2 Suppl):29-37. PubMed ID: 16908338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
    Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
    Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
    Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
    J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.
    Capo' JP; Laramée C; Lucente V; Fakhoury A; Forero-Schwanhaeuser S
    Int J Clin Pract; 2008 Jan; 62(1):39-46. PubMed ID: 18036164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?
    Frost MH; Reeve BB; Liepa AM; Stauffer JW; Hays RD;
    Value Health; 2007; 10 Suppl 2():S94-S105. PubMed ID: 17995479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.
    Toglia MR; Serels SR; Laramée C; Karram MM; Nandy IM; Andoh M; Seifeldin R; Forero-Schwanhaeuser S
    Postgrad Med; 2009 Sep; 121(5):151-8. PubMed ID: 19820284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of patient satisfaction questionnaire in allergic rhinitis].
    Okuda M; Ohkubo K; Goto M
    Arerugi; 2004 Dec; 53(12):1195-202. PubMed ID: 15799305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian version of Qualiveen-30: cultural adaptation of a neurogenic urinary disorder-specific instrument.
    Bonniaud V; Bryant D; Pilati C; Menarini M; Lamartina M; Guyatt G; Del Popolo G
    Neurourol Urodyn; 2011 Mar; 30(3):354-9. PubMed ID: 21305589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder.
    Colman S; Chapple C; Nitti V; Haag-Molkenteller C; Hastedt C; Massow U
    Urology; 2008 Oct; 72(4):803-7. PubMed ID: 18722655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence.
    Schurch B; Denys P; Kozma CM; Reese PR; Slaton T; Barron R
    Arch Phys Med Rehabil; 2007 May; 88(5):646-52. PubMed ID: 17466735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.